NYSE · CIK 0001192448 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
GLAUKOS Corp
GKOS chart by TradingView
PRICE HISTORY
LIVE · NYSEGKOS chart by TradingView
- REVENUE FY2025 ENDED DEC 2025
- $0.5B
- EBITDA
- $-0.2B
- FREE CASH FLOW
- $-0.0B
- EPS
- $-3.28
- GROSS MARGIN
- 55.72%
- ROIC
- —
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET
VALUATION
what you pay for a unit of the business7 CHARTS⤢
P / E RATIO (TTM)
—
-78%145.3x666.0x
⤢
P / SALES (TTM)
13.4x
-6%6.1x21.5x
⤢
P / BOOK
12.0x
-5%3.3x15.7x
⤢
EV / EBITDA (TTM)
—
⤢
EV / REVENUE (TTM)
—
⤢
FCF YIELD (TTM)
-0.15%
-0.6pp-4.34%2.05%
⤢
DIVIDEND YIELD (TTM)
—
GROWTH
is the business getting bigger5 CHARTS⤢
REVENUE
$0.2B
+528%⤢
EBITDA (DERIVED)
$-0.0B
-535%⤢
NET INCOME
$-0.0B
-1686%⤢
EPS (DILUTED)
$-0.31
-1098%⤢
REVENUE GROWTH YOY
49.54%
-6.1pp-46.15%147.46%
PROFITABILITY & RETURNS
what survives to the bottom, and what it earns on capital4 CHARTS⤢
FCF MARGIN
6.51%
+3.4pp-50.98%25.46%
⤢
RETURN ON CAPITAL
—
⤢
RETURN ON EQUITY (TTM)
-27.55%
-29.5pp-31.25%3.86%
MARGIN FUNNEL
every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the businessGROSS MARGIN81.67%
OPERATING MARGIN-9.30%
NET MARGIN-9.90%
FCF MARGIN6.51%
CASH & CAPITAL
where the money actually goes5 CHARTS⤢
FREE CASH FLOW
$0.0B
+1225%⤢
STOCK-BASED COMP
$0.0B
+988%⤢
CAPITAL EXPENDITURE
$0.0B
-9%⤢
SHARES OUTSTANDING
0.06B
+59%⤢
DIVIDEND / SHARE
—
BALANCE SHEET
how much cushion there is3 CHARTS⤢
CASH & EQUIVALENTS
$0.1B
+2195%⤢
TOTAL DEBT
—
⤢
DEBT / EBITDA (TTM)
—
OWNERSHIP
10 LARGEST HOLDERS · WHO OWNS THE FLOATINSTITUTIONS 103.68%INSIDERS 3.60%OTHER / RETAIL 0.00%476 INSTITUTIONAL FILERS
| HOLDER | % HELD | SHARES | VALUE | CHANGE |
|---|---|---|---|---|
| Blackrock Inc. | 15.41% | 9.1M | $1.64B | -0.8% |
| Janus Henderson Group PLC | 9.07% | 5.3M | $962.8M | +77.2% |
| Primecap Management Company | 5.71% | 3.4M | $606.8M | -0.2% |
| Vanguard Portfolio Management LLC | 5.44% | 3.2M | $577.6M | NEW |
| Vanguard Capital Management LLC | 4.25% | 2.5M | $451.6M | NEW |
| State Street Corporation | 3.70% | 2.2M | $392.9M | +2.8% |
| Ameriprise Financial, Inc. | 2.73% | 1.6M | $290.0M | -23.4% |
| Citadel Advisors Llc | 2.45% | 1.4M | $260.5M | +5267.7% |
| Alliancebernstein L.P. | 2.37% | 1.4M | $251.6M | -15.0% |
| Holocene Advisors, LP | 2.35% | 1.4M | $249.1M | +6.5% |
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.